These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 2504243
1. Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. Canadian Zidovudine Multi-Centre Study Group. Rooke R, Tremblay M, Soudeyns H, DeStephano L, Yao XJ, Fanning M, Montaner JS, O'Shaughnessy M, Gelmon K, Tsoukas C. AIDS; 1989 Jul; 3(7):411-5. PubMed ID: 2504243 [Abstract] [Full Text] [Related]
2. Zidovudine-resistant and -sensitive HIV-1 isolates from patients on drug therapy: in vitro studies evaluating level of replication-competent viruses and cytopathogenicity. Tremblay M, Rooke R, Wainberg MA. AIDS; 1992 Dec; 6(12):1445-9. PubMed ID: 1492930 [Abstract] [Full Text] [Related]
3. Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus. Richman DD. Am J Med; 1990 May 21; 88(5B):8S-10S. PubMed ID: 2186629 [Abstract] [Full Text] [Related]
4. Characterization of zidovudine resistant variants of HIV-1 isolated from patients on prolonged therapy. Wainberg MA, Tremblay M, Rooke R, Fanning M, Tsoukas C, Montaner JS, O'Shaughnessy M, Ruedy J. Drugs Exp Clin Res; 1992 May 21; 18(7):283-90. PubMed ID: 1295721 [Abstract] [Full Text] [Related]
5. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Larder BA, Darby G, Richman DD. Science; 1989 Mar 31; 243(4899):1731-4. PubMed ID: 2467383 [Abstract] [Full Text] [Related]
8. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients. Mohri H, Singh MK, Ching WT, Ho DD. Proc Natl Acad Sci U S A; 1993 Jan 01; 90(1):25-9. PubMed ID: 7678340 [Abstract] [Full Text] [Related]
11. Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants. Kim EY, Vrang L, Oberg B, Merigan TC. AIDS Res Hum Retroviruses; 2001 Mar 20; 17(5):401-7. PubMed ID: 11282008 [Abstract] [Full Text] [Related]
14. Development of resistance to zidovudine in HIV strains isolated from CD4+ lymphocytes and plasma during therapy. Nielsen C, Gøtzsche PC, Nielsen CM, Gerstoft J, Vestergaard BF. Antiviral Res; 1992 Jun 20; 18(3-4):303-16. PubMed ID: 1358026 [Abstract] [Full Text] [Related]
15. Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine. Gao WY, Johns DG, Tanaka M, Mitsuya H. Mol Pharmacol; 1999 Mar 20; 55(3):535-40. PubMed ID: 10051538 [Abstract] [Full Text] [Related]
16. Long-term persistence of zidovudine resistance mutations in plasma isolates of human immunodeficiency virus type 1 of dideoxyinosine-treated patients removed from zidovudine therapy. Smith MS, Koerber KL, Pagano JS. J Infect Dis; 1994 Jan 20; 169(1):184-8. PubMed ID: 7506280 [Abstract] [Full Text] [Related]
18. Characterization of reverse transcriptase activity and susceptibility to other nucleosides of AZT-resistant variants of HIV-1. Results from the Canadian AZT Multicentre Study. Wainberg MA, Tremblay M, Rooke R, Blain N, Soudeyns H, Parniak MA, Yao XJ, Li XG, Fanning M, Montaner JS. Ann N Y Acad Sci; 1990 Jan 20; 616():346-55. PubMed ID: 1706573 [No Abstract] [Full Text] [Related]